
|Articles|May 14, 2014
Continuous Manufacturing in Solid-Dosage Drug Production, an Interview with Doug Hausner, C-SOPS
An interview with Doug Hausner, C-SOPS, about continuous manufacturing
Advertisement
Continuous manufacturing offers the potential for improved quality, higher production efficiency, and smaller, more flexible equipment. Doug Hausner, Associate Director for the Engineering Research Center for Structured Organic Particulate Systems (C-SOPS) based at Rutgers University in New Jersey, USA, speaks with Pharmaceutical Technology about the current and future use of continuous processes in solid-dosage drug production.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
Rare Disease Treatments: Navigating the Economics of Global Innovation
4
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
5




